Panagora Asset Management Inc Biogen Inc. Transaction History

Panagora Asset Management Inc

$19.7 Billion
Q2 2024

A detailed history of Panagora Asset Management Inc transactions in Biogen Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 9,536 shares of BIIB stock, worth $1.66 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,536

Previous 14,821 35.66%

Holding current value

$1.66 Million

Previous $3.2 Million 30.83%

% of portfolio

0.01%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$190.52 - $236.72 $1.01 Million - $1.25 Million	-5,285 Reduced 35.66%	9,536 $2.21 Million
Q1 2024 May 07, 2024	SELL	$212.02 - $267.71 $114,278 - $144,295	-539 Reduced 3.51%	14,821 $3.2 Million
Q4 2023 Feb 08, 2024	SELL	$222.59 - $267.94 $24.6 Million - $29.6 Million	-110,392 Reduced 87.79%	15,360 $3.97 Million
Q3 2023 Oct 31, 2023	SELL	$253.3 - $285.89 $20.3 Million - $22.9 Million	-80,145 Reduced 38.92%	125,752 $32.3 Million
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $730,513 - $844,131	-2,654 Reduced 1.27%	205,897 $58.6 Million
Q1 2023 May 11, 2023	BUY	$256.56 - $292.34 $28 Million - $31.9 Million	109,152 Added 109.81%	208,551 $58 Million
Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $1.01 Million - $1.23 Million	-4,006 Reduced 3.87%	99,399 $27.5 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $1.41 Million - $1.94 Million	7,234 Added 7.52%	103,405 $27.6 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $18.1 Million - $21.5 Million	-96,403 Reduced 50.06%	96,171 $19.6 Million
Q1 2022 May 12, 2022	BUY	$193.77 - $244.14 $4.23 Million - $5.32 Million	21,807 Added 12.77%	192,574 $40.6 Million
Q4 2021 Feb 10, 2022	BUY	$223.92 - $287.77 $23 Million - $29.5 Million	102,527 Added 150.24%	170,767 $41 Million
Q3 2021 Nov 10, 2021	SELL	$282.99 - $369.05 $646,066 - $842,541	-2,283 Reduced 3.24%	68,240 $19.3 Million
Q2 2021 Aug 11, 2021	SELL	$259.0 - $414.71 $38.9 Million - $62.3 Million	-150,301 Reduced 68.06%	70,523 $24.4 Million
Q1 2021 May 12, 2021	SELL	$242.95 - $284.63 $1.95 Million - $2.28 Million	-8,023 Reduced 3.51%	220,824 $61.8 Million
Q4 2020 Feb 10, 2021	BUY	$236.26 - $355.63 $6.54 Million - $9.85 Million	27,700 Added 13.77%	228,847 $56 Million
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $2.37 Million - $2.74 Million	8,950 Added 4.66%	201,147 $57.1 Million
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $6.11 Million - $8.09 Million	-23,609 Reduced 10.94%	192,197 $51.4 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $23 Million - $29.2 Million	-85,664 Reduced 28.42%	215,806 $68.3 Million
Q4 2019 Feb 12, 2020	BUY	$220.06 - $304.07 $8.02 Million - $11.1 Million	36,442 Added 13.75%	301,470 $89.5 Million
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $30 Million - $33.6 Million	-137,895 Reduced 34.22%	265,028 $61.7 Million
Q2 2019 Aug 09, 2019	SELL	$219.29 - $241.72 $14.1 Million - $15.6 Million	-64,456 Reduced 13.79%	402,923 $94.2 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $21.9 Million - $34.3 Million	-101,122 Reduced 17.79%	467,379 $110 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $54.9 Million - $69.6 Million	197,209 Added 53.11%	568,501 $171 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $3.34 Million - $4.37 Million	-11,378 Reduced 2.97%	371,292 $131 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $5.88 Million - $7.01 Million	-22,838 Reduced 5.63%	382,670 $111 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $20 Million - $28.3 Million	76,990 Added 23.44%	405,508 $111 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $82,755 - $92,692	-269 Reduced 0.08%	328,518 $105 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $92.4 Million - $108 Million	328,787	328,787 $103 Million

Others Institutions Holding BIIB

# of Institutions

1,016

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account

Panagora Asset Management Inc Biogen Inc. Transaction History